4.7 Review

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review

Jaume Alijotas-Reig et al.

Summary: Antiphospholipid syndrome is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody positivity. Inflammatory and thrombotic mechanisms play a role in its pathophysiology. The standard-of-care treatment is low-dose aspirin and prophylactic low molecular weight heparin, with additional medications considered for refractory cases.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus

Tatiana Reshetnyak et al.

Summary: This study investigates the role of IgA antibodies to cardiolipin (aCL) and IgA antibodies to beta-2 glycoprotein 1 (anti-beta(2)-GP1) in the development of vascular complications in patients with antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE). The results show that the levels of IgA aCL and IgA anti-beta(2)-GP1 are significantly higher in APS patients compared to SLE patients and the control group. These antibodies are closely associated with thrombosis in APS, demonstrating high specificity but low sensitivity for the diagnosis of APS.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients

Natasa Stanisavljevic et al.

Summary: This study revealed that ADMA and hsCRP concentrations are significantly elevated in APS patients and correlated with endothelial dysfunction. ADMA may serve as a simple tool for verifying the presence of endothelial dysfunction in APS patients. The results suggest that hsCRP, along with aPL, may have a preparatory effect on the endothelium in causing endothelial dysfunction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome

Ariadna Anunciacion-Llunell et al.

Summary: Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterized by the presence of antiphospholipid antibodies (aPL) associated with vascular thrombosis and/or pregnancy complications. The study found that OAPS and TAPS patients displayed different but overlapping clusters based on their aPL reactivities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Hematology

Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications

Shruti Chaturvedi et al.

Summary: Antiphospholipid syndrome (APS) is an acquired thromboinflammatory disorder characterized by the presence of antiphospholipid antibodies and an increased risk of venous or arterial thrombosis, with a severe form known as catastrophic APS (CAPS). Complement activation via antiphospholipid antibodies can cause cellular injury and promote coagulation, leading to a potential increase in risk for development of severe thrombotic APS and CAPS in a subset of patients with germline variants in genes crucial for complement regulation. Complement inhibition may be a promising therapy to reduce morbidity and mortality in these patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Review Immunology

Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis

Isabel Johanna Walter et al.

Summary: This study identified previous thrombosis, laboratory category I, triple positivity, and lupus anticoagulant positivity as the most important predictors of adverse pregnancy outcomes.

AUTOIMMUNITY REVIEWS (2021)

Article Medicine, General & Internal

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss

Daniel E. Pleguezuelo et al.

Summary: This study showed that criteria aPL were absent in the majority of patients with recurrent early miscarriage, fetal loss, and extra-criteria recurrent pregnancy loss. However, aPS/PT antibodies were positive in a significant portion of these patients. The presence of aPS/PT antibodies posed a higher risk for recurrent pregnancy loss, but successful live births were achieved in patients who received appropriate treatment.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, General & Internal

Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated

Barbara Ruaro et al.

Summary: This study found a significant correlation between the presence of antiphospholipid antibody positivity and pulmonary embolism events in sarcoidosis patients. There was no significant difference in smoking habit, obesity, or hereditary thrombophilia frequency between the two groups with and without pulmonary embolism.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Rheumatology

Antiphospholipid syndrome

Lisa R. Sammaritano

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2020)

Review Biochemistry & Molecular Biology

MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS)

Przemyslaw J. Kotyla et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Developmental Biology

Cellular Mechanisms of NETosis

Hawa Racine Thiam et al.

Annual Review of Cell and Developmental Biology (2020)

Review Immunology

Non-criteria antiphospholipid syndrome: A nomenclature proposal

Gilberto Pires da Rosa et al.

AUTOIMMUNITY REVIEWS (2020)

Review Immunology

NETosis, complement, and coagulation: a triangular relationship

Cynthia M. de Bont et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

Article Rheumatology

The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study

Ali Duarte-Garcia et al.

ARTHRITIS & RHEUMATOLOGY (2019)

Review Immunology

Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts

Karl J. Lackner et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)

Article Hematology

Extracellular Vesicles in the Antiphospholipid Syndrome

Shruti Chaturvedi et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)

Review Rheumatology

Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

Pier Luigi Meroni et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

Review Medicine, Research & Experimental

The antiphospholipid syndrome: from pathophysiology to treatment

Simone Negrini et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2017)

Review Immunology

The antiphospholipid syndrome in patients with systemic lupus erythematosus

Guillermo J. Pons-Estel et al.

JOURNAL OF AUTOIMMUNITY (2017)

Article Hematology

Antiphospholipid syndrome

Ricard Cervera

THROMBOSIS RESEARCH (2017)

Review Hematology

Pathogenesis and management of antiphospholipid syndrome

Deepa R. J. Arachchillage et al.

BRITISH JOURNAL OF HAEMATOLOGY (2017)

Article Obstetrics & Gynecology

Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study

Gabriele Saccone et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)

Article Hematology

Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study

T. Marchetti et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

Article Multidisciplinary Sciences

'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'

C. Perez-Sanchez et al.

SCIENTIFIC REPORTS (2016)

Review Immunology

Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder

Silvia D'Ippolito et al.

AUTOIMMUNITY REVIEWS (2014)

Article Obstetrics & Gynecology

Evaluation and treatment of recurrent pregnancy loss: a committee opinion

FERTILITY AND STERILITY (2012)

Review Rheumatology

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Pier Luigi Meroni et al.

NATURE REVIEWS RHEUMATOLOGY (2011)

Article Reproductive Biology

Antiphospholipid Antibodies Affect Human Endometrial Angiogenesis

Nicoletta Di Simone et al.

BIOLOGY OF REPRODUCTION (2010)

Review Medicine, General & Internal

Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future

Ali A. Mehdi et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)

Review Hematology

Antiphospholipid antibodies and the antiphospholipid syndrome: Pathogenic mechanisms

Silvia S. Pierangeli et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)

Article Multidisciplinary Sciences

Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6

Yeny Martinez de la Torre et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Multidisciplinary Sciences

β2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa:: Loss of inhibition by clipped β2-glycoprotein I

T Shi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

G Girardi et al.

NATURE MEDICINE (2004)

Article Biochemistry & Molecular Biology

Impaired thrombin generation in β2-glycoprotein I null mice

YH Sheng et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)